Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor

Cancer Science

Volumn 104, Issue 4, 2013, Pages 431-436

  Nishida, Sachiyo ^a   Hirohashi, Yoshihiko ^a   Torigoe, Toshihiko ^a   Inoue, Ryuta ^a   Kitamura, Hiroshi ^a   Tanaka, Toshiaki ^a   Takahashi, Akari ^a   Asanuma, Hiroko ^a   Masumori, Naoya ^a   Tsukamoto, Taiji ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; COMPLEMENTARY DNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA;

ARTICLE; AUTOCRINE EFFECT; CANCER STEM CELL; CELL ASSAY; CELL ISOLATION; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; GENE KNOCKOUT TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MET; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875605329     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12104     Document Type: Article

References (18)

1. Park CY, Tseng D, Weissman IL. Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol Ther 2009; 17: 219-30.
2. Hirohashi Y, Torigoe T, Inoda S et al. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Immunotherapy 2010; 2: 201-11.
3. Nishida S, Hirohashi Y, Torigoe T et al. Gene expression profiles of prostate cancer stem cells isolated by ALDH activity assay. J Urol 2012; 188: 294-9.
4. Cecchi F, Rabe DC, Bottaro DP. Targeting the HGF/Met signalling pathway in cancer. Eur J Cancer 2010; 46: 1260-70.
5. Inoda S, Hirohashi Y, Torigoe T et al. Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. J Immunother 2009; 32: 474-85.
6. Michifuri Y, Hirohashi Y, Torigoe T et al. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol Int 2012; 62: 684-9.
7. van Leenders GJ, Sookhlall R, Teubel WJ et al. Activation of c-MET induces a stem-like phenotype in human prostate cancer. PLoS ONE 2011; 6: e26753.
8. Gu G, Yuan J, Wills M, Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007; 67: 4807-15.
9. Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1993; 1155: 357-71.
10. Peruzzi B, Bottaro DP. Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 2006; 12: 3657-60.
11. Bottaro DP, Rubin JS, Faletto DL et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-4.
12. Knudsen BS, Edlund M. Prostate cancer and the met hepatocyte growth factor receptor. Adv Cancer Res 2004; 91: 31-67.
13. Humphrey PA, Zhu X, Zarnegar R et al. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 1995; 147: 386-96.
14. Kasai S, Sugimura K, Matsumoto K, Nishi N, Kishimoto T, Nakamura T. Hepatocyte growth factor is a paracrine regulator of rat prostate epithelial growth. Biochem Biophys Res Commun 1996; 228: 646-52.
15. Knudsen BS, Gmyrek GA, Inra J et al. High expression of the Met receptor in prostate cancer metastasis to bone. Urology 2002; 60: 1113-7.
16. Tu WH, Zhu C, Clark C, Christensen JG, Sun Z. Efficacy of c-Met inhibitor for advanced prostate cancer. BMC Cancer 2010; 10: 556.
17. Toiyama Y, Yasuda H, Saigusa S et al. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Int J Cancer 2011; 130: 2912-21.
18. Vermeulen L, De Sousa E, Melo F, van der Heijden M et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-76.